Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2026-02-07 @ 6:43 AM
Study NCT ID:
NCT05692050
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2023-02-03
First Post:
2023-01-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access to Epcoritamab
Sponsor:
AbbVie
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma | View |